SECURITIES AND EXCHANGE COMMISSION
Washington, D. C. 20549
FORM 8-K
CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE
SECURITIES EXCHANGE ACT OF 1934
Date of Report (Date of earliest event reported): August 9, 2004
HALSEY DRUG CO., INC.
616 N. North Court, Suite 120, Palatine, Illinois 60067
(847-705-7709)
Incorporated under the laws of | Commission File Number | I.R.S. Employer Identification Number |
Item 12. Results of Operations and Financial Condition
On August 9, 2004, Halsey Drug Co., Inc. (the "Company") issued a press release disclosing the financial results for its second quarter ended June 30, 2004 and the six months ended June 30, 2004. A copy of the Company's press release is attached as Exhibit 99.1 hereto.
Item 7. Financial Statements, Pro Forma Financial Information and Exhibits.
(b) Exhibits
Exhibit
Number Description
Number Description
99.1 Press Release dated August 9, 2004 Announcing Results for Second Quarter ended June 30, 2003
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.
HALSEY DRUG CO., INC. | ||
| | |
Date: August 9, 2004 | By: | /s/ Peter A. Clemens |
Peter A. Clemens | ||
Senior Vice President & Chief Financial Officer |
EXHIBIT INDEX
Exhibit
Number Description
Number Description
99.1 Press Release dated August 9, 2004 Announcing Results for Second Quarter ended June 30, 2004.